A5020634613- Cardiac Valve Diseases and Treatments
- Cardiac Structural Anomalies and Repair
- Cardiomyopathy and Myosin Studies
- Cardiac and Coronary Surgery Techniques
- Congenital Heart Disease Studies
- Vascular Anomalies and Treatments
- Mechanical Circulatory Support Devices
- Pulmonary Hypertension Research and Treatments
- Infective Endocarditis Diagnosis and Management
- Obstructive Sleep Apnea Research
- Vasculitis and related conditions
- Trauma, Hemostasis, Coagulopathy, Resuscitation
- Cardiac pacing and defibrillation studies
- Atrial Fibrillation Management and Outcomes
- Cardiovascular Function and Risk Factors
- Aortic Disease and Treatment Approaches
- Cardiac Arrhythmias and Treatments
- Blood donation and transfusion practices
Chinese Academy of Medical Sciences & Peking Union Medical College
2022-2023
Guangdong Academy of Medical Sciences
2019-2022
Guangdong Provincial People's Hospital
2019-2022
Shantou University Medical College
2020-2021
Shantou University
2020-2021
Hennepin County Medical Center
1997
University of Minnesota
1997
Amgen (United States)
1997
To compare surgical outcomes after mitral valve replacement via either minimally invasive thoracoscopic (MIs) or traditional median sternotomy (MS) surgery and determine the short- mid-term clinical of MI approach.All patients who received MIs (n=405) MS (n=691) at Guangdong Cardiovascular Institute between January 2012 July 2015 were analyzed for outcome differences due to approach using propensity score matching. The best 202 matches from group analyzed. data two groups collected,...
The aims of the present study was to compare midterm results quadrangular leaflet resection versus chordal replacement for repair degenerative posterior mitral (PML) prolapse, and explore risk factors recurrent severe regurgitation (MR).From January 2012 December 2018, 1,423 consecutive patients underwent valve (MV) repair. A total 317 had PML prolapse constituted population. Of these, 74 (23.3%) resection, 243 (76.7%) replacement. Outcomes were compared by using unadjusted data propensity...
To objectively evaluate the feasibility, safety, effectiveness and short-term outcome of totally thoracoscopic mitral valve replacement via two port approach, we conducted a retrospective study comparing approach with three for replacement.Data all were analyzed from Guangdong Cardiovascular Institute between January 1, 2016 December 31, 2017. account selection bias one-to-one propensity score caliper matching without was performed. The clinical data groups collected, including preoperative...
The thoracoscopic trans-mitral approach can not only facilitate exposure of the ventricular septum, mitral valve, and subvalvular apparatus, it also enables surgeons to perform concomitant valve intervention. This study aimed determine safety efficacy septal myectomy in elderly patients with hypertrophic obstructive cardiomyopathy (HOCM).We reviewed demographic clinical characteristics outcomes who underwent our center between April 2019 2021. population was divided into a younger group (<60...
Transaortic myectomy is a common procedure for patients with hypertrophic obstructive cardiomyopathy. Thoracoscopic trans-mitral has been described in few small-sample studies and recommended as preferable. We herein report our clinical outcomes using the thoracoscopic approach 76 patients.This retrospective single-centre analysis of safety efficacy by comparing that transaortic myectomy.Between April 2019 October 2021, 132 underwent either (n = 56) or 76). Compared those group, group were...
The transaortic Morrow procedure is the current gold standard for hypertrophic obstructive cardiomyopathy (HOCM) patients who are resistant to maximum drug therapy. It controversial whether concomitant mitral valve intervention necessary. Only a few centers apply anterior leaflet extension with bovine or autologous pericardial patch further decrease systolic motion. Our aim assess primeval outcomes of thoracoscopic transmitral myectomy (TTM-AMLE) in symptomatic HOCM patients.Between April...
Background: Transcatheter mitral valve-in-valve implantation (TM-VIV) has emerged as a viable and attractive alternative to surgical valve replacement (SMVR). This study aimed review single-center experience with redo procedure for bioprostheses failure over an 8-year period. In addition, it compared procedural safety early outcomes of various approaches.
Isolated pulmonary vasculitis (IPV) is a rare, insidious, and localized inflammatory disease affecting the arteries, often leading to severe luminal obstruction. The prognosis for patients with occlusive IPV poor, there currently lack of effective treatments. objective this study was evaluate performance endarterectomy (PEA) as treatment IPV.This single-center retrospective analysis included who received PEA between January 2018 June 2022. Clinical characteristics hemodynamic parameters were...
This study aimed to summarize the perioperative and long-term outcomes of patients with previous mitral valve surgery (MVS) undergoing reoperative replacement (MVR).Data for all replacements (re-MVRs) or without concomitant tricuspid were analyzed from Guangdong Provincial People's Hospital between January 2013 December 2019. Propensity score matching resulted in 30 matched pairs improved balance after baseline covariates. Perioperative data clinical analyzed.Results are based on cohorts two...
Failed mitral bioprosthesis has conventionally been treated with redo surgical valve replacement (SMVR). Transcatheter valve-in-valve implantation (TM-VIVI) is emerging as an alternative to SMVR in high-risk patients. We report our experience transapical TM-VIVI using the J-Valve system.From May 2020 January 2021, 21 patients a failed underwent without concomitant procedures at Guangdong Provincial People's hospital. The mean age was 74.62 years. All were heavily symptomatic severe...
The wide adoption of the MitraClip procedure in clinical practice inevitably causes increases surgical intervention demand for patients following failed implantation. Current reports about after focused on open-heart surgery. In this case, totally thoracoscopic third-time redo mitral valve replacement was successfully performed a high-risk patient, aortic and procedure.
Background: Obstructive sleep apnea (OSA) is common in patients with chronic thromboembolic pulmonary hypertension (CTEPH), but the pathological determinants of adverse outcomes remain unknown. This study aimed to investigate prognostic significance various parameters CTEPH undergoing endarterectomy. Methods: Consecutive diagnosed who underwent overnight cardiorespiratory polygraphy for assessment OSA were enrolled. Time-to-event analysis was performed investigating indices (e.g.,...